Status:
RECRUITING
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
Lead Sponsor:
Fundación Española de Hematología y Hemoterapía
Conditions:
ITP - Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)
Eligibility:
All Genders
2+ years
Brief Summary
Primary immune thrombocytopenia (PIT), previously referred to as idiopathic thrombocytopenic purpura, is an acquired disease characterized by accelerated platelet destruction and deficient platelet pr...
Eligibility Criteria
Inclusion
- Children as young as 2 months of age and adults in follow-up since 2015 (irrespective of date of diagnosis) with the diagnostic presumption of PIT or other thrombocytopenia of probable immune origin defined as a platelet count \< 100 x 109/L.
- Patients who have given written informed consent. In the case of deceased patients, the data will be included in the registry and the investigator will record the impossibility of collecting patient's informed consent form due to death. Only patients deceased after December 31 2015, will be included
Exclusion
- Patients who, at the investigator's discretion, do not meet the conditions for inclusion in the study
Key Trial Info
Start Date :
September 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2034
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06919341
Start Date
September 27 2024
End Date
September 1 2034
Last Update
April 9 2025
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Complexo Hospitalario Universitario A Coruña
A Coruña, A Coruña, Spain, 15006
2
Hospital Universitario Son Espases
Palma, Balearic Islands, Spain, 07120
3
Hospital Del Mar
Barcelona, Barcelona, Spain, 08003
4
Hospital Vall d'Hebron (
Barcelona, Barcelona, Spain, 08035